In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute contextualizes updates to the standard of care, relays the latest developments in immunotherapy, and offers insight into best practices for the incorporation of novel agents in your clinical practice.
Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7265
© 2017 Imedex, LLC.
Advertisement